↓ Skip to main content

Safety of disease-modifying treatments in SARS-CoV-2 antibody-positive multiple sclerosis patients

Overview of attention for article published in Multiple Sclerosis and Related Disorders, January 2021
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (79th percentile)
  • Good Attention Score compared to outputs of the same age and source (73rd percentile)

Mentioned by

blogs
1 blog
twitter
1 X user

Citations

dimensions_citation
14 Dimensions

Readers on

mendeley
84 Mendeley